In ACC, Ruggiero et al. found that the HSPA5 inhibitor HA15 synergized with mitotane action against adrenocortical carcinoma cells through convergent activation of endoplasmic reticulum stress pathways (50). This evidence concerns the gene HSPA5 and adrenal cortex carcinoma.